Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
about
The changing epidemiology of Clostridium difficile infections[Clostridium difficile infections in geriatric patients].Typing Clostridium difficile strains based on tandem repeat sequences.Detection of Clostridium difficile infection clusters, using the temporal scan statistic, in a community hospital in southern Ontario, Canada, 2006-2011Clostridium difficile is not associated with outbreaks of viral gastroenteritis in the elderly in the Netherlands.Clinical Clostridium difficile: clonality and pathogenicity locus diversity.Clostridium difficile and methicillin-resistant Staphylococcus aureus shedding by slaughter-age pigs.Epidemiology of Clostridium difficile infectionClostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.Host immunity to Clostridium difficile PCR ribotype 017 strains.Comparison of strain typing results for Clostridium difficile isolates from North America.Clostridium difficile infection in an endemic setting in the NetherlandsIncreased sporulation rate of epidemic Clostridium difficile Type 027/NAP1Hypervirulent strains of Clostridium difficile.Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.Genetic relatedness of Clostridium difficile isolates from various origins determined by triple-locus sequence analysis based on toxin regulatory genes tcdC, tcdR, and cdtR.Carriage of Clostridium difficile by wild urban Norway rats (Rattus norvegicus) and black rats (Rattus rattus).Clostridium difficile in paediatric populations.Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit.Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population.Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation.Toxic megacolon from hypervirulent Clostridium difficile infection (ribotype 027) following elective total knee replacement: an emerging challenge in modern health care.Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens.Morphological and genetic diversity of temperate phages in Clostridium difficileAll-cause and disease-specific mortality in hospitalized patients with Clostridium difficile infection: a multicenter cohort study.Typing and subtyping of Clostridium difficile isolates by using multiple-locus variable-number tandem-repeat analysis.Metronidazole resistance in Clostridium difficile is heterogeneous.Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets.Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans.Le Clostridium difficile dans les populations d’âge pédiatrique.
P2860
Q28750385-1C3F4AB8-13A8-46DD-A617-698856227A90Q30244040-43657B50-F20D-4988-A24C-4D5609EA8E51Q33398660-C42255ED-5A93-44FA-A3AF-1744E7CC8955Q33646483-F3CD9514-B9CA-4E31-9CFF-CFEA2C18652BQ33853771-8BA84370-3376-4D56-942B-C975DD9C5FFBQ33916437-54E4B11C-9702-4E58-8EFA-D8B3DA269D1BQ33972040-46ABEFDE-BA5F-426A-B87E-C315196AE16DQ34027474-1F55DCEF-FDB2-4DA0-9483-A206E38F85FAQ34046334-26ED67F0-3CD2-4226-865C-DDAEF8692293Q34570947-DA726952-1006-4AE6-93D2-2185065C80D0Q34595635-98419EAC-BFD2-4BDE-9A5F-A697E7EF34CEQ34627447-8ECD54ED-930D-41A3-BC4C-D0A04945FA2FQ34641408-B74C4820-232E-4E1F-AC6A-9A305B8E578DQ36539739-52FB3AF5-A33D-4789-AD04-6960EE267163Q36815464-BA62CA15-A6F7-469C-8D28-7E5D9A3B0261Q36826679-209B4178-5BE2-4E92-BFA9-ED6047E7E014Q36870734-1BD199DA-85B2-4742-A80C-7D0918F717EBQ36958021-1248341C-213A-4E94-AFBB-100C7EAFCD26Q37545356-35EA453E-DD22-4ED8-9913-F6570DD0A6EFQ37609568-EBF9AABB-D06D-4317-84FC-48AB6C0214BBQ38106746-4494683E-DBC2-4E5F-B645-8EC73C9114C8Q38542515-4853AD75-08D0-4028-B28A-115759482BE8Q38558966-DA9B1493-05E9-4AFB-8CAA-B137AAB39DFEQ38899041-D9210D24-F0DA-4817-AEFF-69CA9D6B86D1Q39665226-C9B0F7C8-DD80-4E52-B546-2F62D10882E2Q39755382-9C9E4F6A-569E-40D0-9F16-C8DABFE19395Q40335974-0F5ED5F5-9AAA-4536-A2F4-4A2C471FA99AQ40357181-2A713C84-2CF6-4E8A-8038-B4A3CA26C080Q40438125-BE1DC648-0B6C-4BBF-8C7D-72A7902A934FQ40458839-B511744C-0253-4819-856D-101221B98563Q40870178-C204263B-F2CE-4D38-884A-700464F44F26Q41922258-2183702B-4D03-4A72-B51B-2846FF669118Q42054085-D7D71F07-A727-4DCB-8738-EFD2E12143EEQ42121694-A2647182-F5F0-40EC-89EE-11AD4E876181Q42279664-82453811-13B7-4E24-B65D-8E38F6CC34BBQ42559525-7B5F6700-19B0-4BC9-B455-A29C40505FE1Q42752873-D1E67C58-B7DA-4964-A068-E1133AC2A945Q42772857-7E0EA78B-8EFC-4B45-84A1-EDD3CCAC4539Q43725125-FFFD6B41-B34E-4324-93D7-9A35D8B86838Q45919083-68C9963C-5E9D-4B99-BC40-90686E515184
P2860
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@ast
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@en
type
label
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@ast
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@en
prefLabel
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@ast
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@en
P2093
P2860
P356
P1476
Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
@en
P2093
Annet Troelstra
Caroline E Visser
Daan W Notermans
Dick Veenendaal
Ed J Kuijper
Renate J van den Berg
Susan van den Hof
Sylvia Debast
Tjallie van der Kooi
P2860
P304
P356
10.3201/EID1205.051350
P577
2006-05-01T00:00:00Z